Advertisement

Researchers at MIT’s Computer Science and Artificial Intelligence Laboratory have devised a new way to combine information from two different kinds of MRI scans, allowing drug developers to map which regions of the brain are affected by certain neurological disorders.

Advertisement
Advertisement